Lazard Freres Gestion S.A.S. Embecta Corp. Transaction History

Lazard Freres Gestion S.A.S.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$15.0 - $22.17 $8,625 - $12,747	-575 Reduced 2.74%	20,405 $306,000
Q2 2023 Aug 10, 2023	SELL	$21.6 - $30.69 $16,372 - $23,263	-758 Reduced 3.49%	20,980 $460,000
Q1 2023 May 09, 2023	SELL	$23.07 - $32.77 $74,908 - $106,404	-3,247 Reduced 13.0%	21,738 $516,000
Q4 2022 Feb 08, 2023	SELL	$25.29 - $35.48 $368,374 - $516,801	-14,566 Reduced 36.83%	24,985 $638,000
Q3 2022 Nov 10, 2022	SELL	$24.0 - $33.42 $116,736 - $162,554	-4,864 Reduced 10.95%	39,551 $1.15 Million
Q2 2022 Jul 28, 2022	BUY	$24.78 - $33.36 $1.1 Million - $1.48 Million	44,415 New	44,415 $1.13 Million

405

51.1M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.17B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Lazard Freres Gestion S.A.S., based on Form 13F filings with the SEC.

Stay updated on Lazard Freres Gestion S.A.S. with notifications on news.